Home » Tenders » Americas » USA » Oligo and Gene Production Tender, USA - 106131587

Oligo and Gene Production Tender, USA - 106131587

HEALTH AND HUMAN SERVICES, DEPARTMENT OF | CENTERS FOR DISEASE CONTROL AND PREVENTION has floated a tender for Oligo and Gene Production. The project location is USA and the tender is closing on 27 Aug 2024. The tender notice number is 75D30124Q78083, while the TOT Ref Number is 106131587. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Oligo and Gene Production

Deadline : 27 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 106131587

Document Ref. No. : 75D30124Q78083

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

The Centers for Disease Control and Prevention (CDC) Influenza Division (ID) is responsible for developing Candidate Vaccine Viruses based on circulating and novel influenza strains. Candidate Vaccine Viruses (CVVs) are reassortant viruses that are used as the starting materials for seasonal and pandemic vaccines. To facilitate the development of the CVVs, CDC uses oligonucleotides and synthetic genes to transcribe the influenza genes to produce the CVVs.

During research on influenza CVVs, many different genes must be constructed, significantly more than is required in CVV production in most cases. The Influenza Division, therefore, requires bulk production of oligonucleotides with relaxed quality standards versus those required for actual CVV production. The sequences will still follow the natural evolution of viruses and, therefore, can still not be predicted.
Active Contract Opportunity
Notice ID : 75D30124Q78083
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : CENTERS FOR DISEASE CONTROL AND PREVENTION
Office: CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Aug 21, 2024 07:33 am EDT
Original Published Date: Aug 02, 2024 08:13 am EDT
Updated Date Offers Due: Aug 27, 2024 03:00 pm EDT
Original Date Offers Due: Aug 21, 2024 05:00 pm EDT
Inactive Policy: 15 days after date offers due
Updated Inactive Date: Sep 11, 2024
Original Inactive Date: Sep 05, 2024
Initiative: None

Classification
Original Set Aside:

Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Atlanta, GA USA